Correction: MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis (Cell Death & Differentiation, (2015), 22, 6, (986-999), 10.1038/cdd.2014.187);MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis

Cell Death and Differentiation

Volumn 22, Issue 6, 2015, Pages 986-999

  Su, M ^a   Wang, J ^a   Wang, C ^a   Wang, X ^a   Dong, W ^b   Qiu, W ^c   Wang, Y ^a   Zhao, X ^d   Zou, Y ^a   Song, L ^a   Zhang, L ^b   Hui, R ^a  

^a FUWAI HOSPITAL   (China)

^b BEIJING HOSPITAL   (China)

^c PEKING UNIVERSITY FIRST HOSPITAL   (China)

^d QINGDAO UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; MICRORNA; P27 ANTIGEN; TARGET OF RAPAMYCIN KINASE;

ANIMAL; APOPTOSIS; AUTOPHAGY; CELL CULTURE; ECHOCARDIOGRAPHY; GENETICS; HEART FAILURE; HEART MUSCLE; MALE; METABOLISM; MOUSE; PHYSIOLOGY; RAT; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; AUTOPHAGY; BLOTTING, WESTERN; CELLS, CULTURED; ECHOCARDIOGRAPHY; HEART FAILURE; MALE; MICE; MICRORNAS; MICROSCOPY, ELECTRON, TRANSMISSION; MYOCARDIUM; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; TOR SERINE-THREONINE KINASES;

EID: 84940001131     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/s41418-020-0582-4     Document Type: Erratum

References (47)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013; 127: e6-e245.
2. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006; 20: 515-524.
3. Wang J, Huang W, Xu R, Nie Y, Cao X, Meng J et al. MicroRNA-24 regulates cardiac fibrosis after myocardial infarction. J Cell Mol Med 2012; 16: 2150-2160.
4. Ucar A, Gupta SK, Fiedler J, Erikci E, Kardasinski M, Batkai S et al. The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun 2012; 3: 1078.
5. Ge Y, Pan S, Guan D, Yin H, Fan Y, Liu J et al. MicroRNA-350 induces pathological heart hypertrophy by repressing both p38 and JNK pathways. Biochim Biophys Acta 2013; 1832: 1-10.
6. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007; 13: 613-618.
7. Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 2009; 119: 2772-2786.
8. Ono K, Kuwabara Y, Han J. MicroRNAs and cardiovascular diseases. FEBS J 2011; 278: 1619-1633.
9. Wang C, Wang S, Zhao P, Wang X, Wang J, Wang Y et al. MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression. J Cell Biochem 2012; 113: 2040-2046.
10. Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell 2004; 6: 463-477.
11. Schramm C, Fine DM, Edwards MA, Reeb AN, Krenz M. The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling. Am J Physiol Heart Circ Physiol 2012; 302: H231-H243.
12. Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 2007; 13: 619-624.
13. Taneike M, Yamaguchi O, Nakai A, Hikoso S, Takeda T, Mizote I et al. Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy 2010; 6: 600-606.
14. Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 2007; 100: 914-922.
15. Zhu H, Tannous P, Johnstone JL, Kong Y, Shelton JM, Richardson JA et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest 2007; 117: 1782-1793.
16. Shih H, Lee B, Lee RJ, Boyle AJ. The aging heart and post-infarction left ventricular remodeling. J Am Coll Cardiol 2011; 57: 9-17.
17. Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, Hidayat S et al. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 2002; 110: 177-189.
18. Shende P, Plaisance I, Morandi C, Pellieux C, Berthonneche C, Zorzato F et al. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation 2011; 123: 1073-1082.
19. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 2001; 3: 1014-1019.
20. Appenzeller-Herzog C, Hall MN. Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling. Trends Cell Biol 2012; 22: 274-282.
21. Shaw RJ, Bardeesy N, Manning BD, Lopez L, Kosmatka M, DePinho RA et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer cell 2004; 6: 91-99.
22. Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 2005; 121: 179-193.
23. Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 2007; 9: 218-224.
24. Jiang H, Martin V, Gomez-Manzano C, Johnson DG, Alonso M, White E et al. The RB-E2F1 pathway regulates autophagy. Cancer Res 2010; 70: 7882-7893.
25. Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 1994; 78: 67-74.
26. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM et al. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 1994; 8: 9-22.
27. Tamamori-Adachi M, Hayashida K, Nobori K, Omizu C, Yamada K, Sakamoto N et al. Down-regulation of p27Kip1 promotes cell proliferation of rat neonatal cardiomyocytes induced by nuclear expression of cyclin D1 and CDK4. Evidence for impaired Skp2-dependent degradation of p27 in terminal differentiation. J Biol Chem 2004; 279: 50429-50436.
28. Thomas RL, Roberts DJ, Kubli DA, Lee Y, Quinsay MN, Owens JB et al. Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure. Genes Dev 2013; 27: 1365-1377.
29. Ceylan-Isik AF, Dong M, Zhang Y, Dong F, Turdi S, Nair S et al. Cardiomyocyte-specific deletion of endothelin receptor A rescues aging-associated cardiac hypertrophy and contractile dysfunction: role of autophagy. Basic Res Cardiol 2013; 108: 335.
30. Kim J, Kundu M, Viollet B, Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011; 13: 132-141.
31. Zhang D, Contu R, Latronico MV, Zhang J, Rizzi R, Catalucci D et al. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J Clin Invest 2010; 120: 2805-2816.
32. Ramos FJ, Chen SC, Garelick MG, Dai DF, Liao CY, Schreiber KH et al. Rapamycin reverses elevated mTORC1 signaling in lamin A/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival. Sci Transl Med 2012; 4: 144ra103.
33. Choi JC, Muchir A, Wu W, Iwata S, Homma S, Morrow JP et al. Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A/C gene mutation. Sci Transl Med 2012; 4: 144ra102.
34. Marin TM, Keith K, Davies B, Conner DA, Guha P, Kalaitzidis D et al. Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation. J Clin Invest 2011; 121: 1026-1043.
35. Petiot A, Ogier-Denis E, Blommaart EF, Meijer AJ, Codogno P. Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem 2000; 275: 992-998.
36. Memmott RM, Dennis PA. Akt-dependent and-independent mechanisms of mTOR regulation in cancer. Cell Signal 2009; 21: 656-664.
37. Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003; 115: 577-590.
38. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 2008; 30: 214-226.
39. Wang RH, Kim HS, Xiao C, Xu X, Gavrilova O, Deng CX. Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance. J Clim Invest 2011; 121: 4477-4490.
40. Li JM, Brooks G. Downregulation of cyclin-dependent kinase inhibitors p21 and p27 in pressure-overload hypertrophy. Am J Physiol 1997; 273(3 Pt 2): H1358-H1367.
41. Burton PB, Yacoub MH, Barton PJ. Cyclin-dependent kinase inhibitor expression in human heart failure. A comparison with fetal development. Eur Heart J 1999; 20: 604-611.
42. Hauck L, Harms C, An J, Rohne J, Gertz K, Dietz R et al. Protein kinase CK2 links extracellular growth factor signaling with the control of p27(Kip1) stability in the heart. Nat Med 2008; 14: 315-324.
43. Sun X, Momen A, Wu J, Noyan H, Li R, von Harsdorf R et al. p27 Protein protects metabolically stressed cardiomyocytes from apoptosis by promoting autophagy. J Biol Chem 2014; 289: 16924-16935.
44. National Academies Press (US)The National Academies Collection: Reports funded by National Institutes of Health. Guide for the Care and Use of Laboratory Animals8th ednNational Academies Press (US): Washington (DC), 2011.
45. Wang X, Wang J, Su M, Wang C, Chen J, Wang H et al. TNNI3K, a cardiac-specific kinase, promotes physiological cardiac hypertrophy in transgenic mice. PLoS ONE 2013; 8: e58570.
46. Kimura S, Noda T, Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 2007; 3: 452-460.
47. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000; 19: 5720-5728.